Table 2.
Differential expression levels of microRNAs associated with time to progression in patients with GBM
| microRNAs |
Time To Progression(TTP) |
||||||||
|---|---|---|---|---|---|---|---|---|---|
| < 9 months | > 9 months | p-value | < 12 months | > 12 months | p-value | < 15 months | > 15 months | p-value | |
| hsa-miR-128b |
7.56 ± 0.76 |
7.59 ± 0.74 |
0.6587 |
7.54 ± 0.75 |
7.67 ± 0.76 |
0.2028 |
7.53 ± 0.73 |
7.76 ± 0.81 |
0.0420 |
| hsa-miR-323 |
6.19 ± 0.29 |
6.20 ± 0.28 |
0.5988 |
6.18 ± 0.29 |
6.22 ± 0.28 |
0.3012 |
6.18 ± 0.29 |
6.26 ± 0.30 |
0.0451 |
| hsa-miR-329 |
6.06 ± 0.19 |
6.07 ± 0.21 |
0.6787 |
6.05 ± 0.20 |
6.07 ± 0.21 |
0.4293 |
6.05 ± 0.19 |
6.10 ± 0.22 |
0.0981 |
| hsa-miR-106a |
9.77 ± 0.77 |
9.95 ± 0.67 |
0.0439 |
9.77 ± 0.75 |
10.03 ± 0.67 |
0.0091 |
9.79 ± 0.73 |
10.03 ± 0.75 |
0.0305 |
| hsa-miR-106b |
10.69 ± 0.67 |
10.93 ± 0.58 |
0.0021 |
10.73 ± 0.67 |
10.91 ± 0.56 |
0.0398 |
10.75 ± 0.65 |
10.88 ± 0.60 |
0.1980 |
| hsa-miR-21 |
14.22 ± 1.11 |
14.01 ± 1.04 |
0.1136 |
14.23 ± 1.07 |
13.86 ± 1.09 |
0.0089 |
14.23 ± 1.07 |
13.74 ± 1.08 |
0.0029 |
| hsa-miR-92 | 10.15 ± 0.62 | 10.28 ± 0.64 | 0.0795 | 10.16 ± 0.62 | 10.32 ± 0.65 | 0.0497 | 10.16 ± 0.60 | 10.38 ± 0.71 | 0.0214 |